INKILNis a novel long noncoding RNA promoting vascular smooth muscle inflammation via scaffolding MKL1 and USP10
Author:
Zhang Wei, Zhao Jinjing, Deng Lin, Ishimwe Nestor, Pauli Jessica, Wu Wen, Shan Shengshuai, Kempf Wolfgang, Ballantyne Margaret D, Kim David, Lyu Qing, Bennett Matthew, Rodor Julie, Turner Adam W., Lu Yao Wei, Gao Ping, Choi Mihyun, Warthi Ganesh, Kim Ha Won, Barroso Margarida MORCID, Bryant William B., Miller Clint L., Weintraub Neal L., Maegdefessel Lars, Miano Joseph M., Baker Andrew H, Long Xiaochun
Abstract
AbstractBackgroundActivation of vascular smooth muscle cells (VSMCs) inflammation is vital to initiate vascular disease. However, the role of human-specific long noncoding RNAs (lncRNAs) in VSMC inflammation is poorly understood.MethodsBulk RNA-seq in differentiated human VSMCs revealed a novel human-specific lncRNA calledINflammatory MKL1InteractingLongNoncoding RNA (INKILN).INKILNexpression was assessed in multiple in vitro and ex vivo models of VSMC phenotypic modulation and human atherosclerosis and abdominal aortic aneurysm (AAA) samples. The transcriptional regulation ofINKILNwas determined through luciferase reporter system and chromatin immunoprecipitation assay. Both loss- and gain-of-function approaches and multiple RNA-protein and protein-protein interaction assays were utilized to uncover the role ofINKILNin VSMC proinflammatory gene program and underlying mechanisms. Bacterial Artificial Chromosome (BAC) transgenic (Tg) mice were utilized to studyINKLINexpression and function in ligation injury-induced neointimal formation.ResultsINKILNexpression is downregulated in contractile VSMCs and induced by human atherosclerosis and abdominal aortic aneurysm.INKILNis transcriptionally activated by the p65 pathway, partially through a predicted NF-κB site within its proximal promoter.INKILNactivates the proinflammatory gene expression in cultured human VSMCs and ex vivo cultured vessels. Mechanistically,INKILNphysically interacts with and stabilizes MKL1, a key activator of VSMC inflammation through the p65/NF-κB pathway.INKILNdepletion blocks ILIβ-induced nuclear localization of both p65 and MKL1. Knockdown ofINKILNabolishes the physical interaction between p65 and MKL1, and the luciferase activity of an NF-κB reporter. Further,INKILNknockdown enhances MKL1 ubiquitination, likely through the reduced physical interaction with the deubiquitinating enzyme, USP10.INKILNis induced in injured carotid arteries and exacerbates ligation injury-induced neointimal formation in BAC Tg mice.ConclusionsThese findings elucidate an important pathway of VSMC inflammation involving anINKILN/MKL1/USP10 regulatory axis. Human BAC Tg mice offer a novel and physiologically relevant approach for investigating human-specific lncRNAs under vascular disease conditions.
Publisher
Cold Spring Harbor Laboratory
Reference85 articles.
1. Vascular consequences of inflammation: a position statement from the ESH Working Group on Vascular Structure and Function and the ARTERY Society;J Hypertens,2020 2. Inflammation, Neointimal Hyperplasia, and Restenosis 3. Cytokine Circuits in Cardiovascular Disease;Immunity,2019 4. Cytokines as therapeutic targets for cardio-and cerebrovascular diseases;Basic Res Cardiol,2021 5. Nguyen, MT , Fernando, S , Schwarz, N , Tan, JT , Bursill, CA , and Psaltis, PJ (2019). Inflammation as a Therapeutic Target in Atherosclerosis. J Clin Med 8.
|
|